Expression and degeneration of tenascin-C in human lung cancers

British Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 98-102

  Kusagawa, H ^a   Onoda, K ^a   Namikawa, S ^a   Yada, I ^a   Okada, A ^a   Yoshida, T ^a   Sakakura, T ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Lung cancer; Metastasis; Tenascin

Indexed keywords

MESSENGER RNA; TENASCIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LUNG CANCER; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0031974930     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.15     Document Type: Article

References (30)

1. Anbazhagen R, Sakakura T and Gusterson BA (1940) The distribution of immunoreactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia. Virchows Arch B Cell Pathol 59: 54-63
2. Borsi L, Carnemolla B, Nicolo G, Spina B, Tanara G and Zardi L (1992) Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 52: 688-692
3. Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ and Bigner DD (1983) Human glioma mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 43: 2796-2805
4. Chiquet-Ehrismann R, Mackie EJ, Pearson AC and Sakakura T (1986) Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47: 131-139
5. Chomczynski P and Sacci N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
6. Chung CY and Erickson HP (1994) Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol 126: 539-548
7. Chung CY, Murphy-Ullrich JE and Erickson HP (1996) Mitogenesis, cell migration, and loss of local adhesions induced by tenascin-C interacting with cell surface receptor, annexin II. Mol Biol Cell 7: 883-892
8. Erickson HP and Bourdon MA (1989) Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol 5: 71-92
9. Hauptmann S, Zardi L, Siri A, Carnemolla B, Borsi L, Castellucci M, Klosterhalfen B, Hartung P, Weis J, Stocker G, Haubeck H-D and Kirkpatrick CJ (1995) Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab Invest 73: 172-182
10. Ibrahim SN, Lightner VA, Ventimiglia JB, Ibrahim JK, Walther PJ, Bigner DD and Humphrey PA (1993) Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. Hum Pathol 24: 982-989
11. Ilunga K and Iriyama K (1995) Expression of tenascin in gastric carcinoma. Br J Surg 82: 948-951
12. Imai K, Kusakabe M, Sukakura T, Nakanishi I and Okada Y (1994) Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases. FEBS Lett 352: 216-218
13. Jones FS and Copertino DW (1996) The molecular biology of tenascin: structure, splice variants, and regulation of gene expression. In Tenascin and Counteradhesive Molecules of the Extracellular Matrix. Crossin KL. (ed.), pp. 1-22, Harwood Academic: The Netherlands
14. Kaplony A, Zimmermann DR, Fischer RW, Imhof BA, Odermatt BF, Winterhalter KH and Vaughan L (1991) Tenascin Mr 220,000 isoform expression correlates with corneal cell migration. Development 112: 605-614
15. Khyse-Andersen J (1984) Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide of nitrocellulose. J Biochem Biophys Meth 10: 203-209
16. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JK, Howeedy AA and Virtanen I (1991) Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum Pathol 22: 636-643
17. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of the bacteriophage. Nature 227: 680-685
18. Mackie EJ, Chiquet-Ehrismann R, Pearson AC, Inaguma Y, Taya K, Kawarada Y and Sakakura T (1987) Tenascin is a stromal marker for epithelial malignancy in mammary gland. Proc Natl Acad Sci USA 84: 4621-4625
19. Murphy-Ullrich J, Lightner VA, Aukhil I, Erickson HP and Hook M (1991) Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 115: 1127-1136
20. Oike Y, Hiraiwa H, Kawakatsu H, Nishikai M, Okinaka T, Suzuki T, Okada A, Yatani R and Sakakura T (1990) Isolation and characterization of human fibroblast tenascin. An extracelluar matrix glycoprotein of interest for developmental studies. Int J Dev Biol 34: 309-317
21. Oyama F, Hirohashi S, Shimosato Y, Titani K and Sekiguchi K (1991) Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin. Cancer Res 51: 4876-4881
22. Riley GP, Harrall RL, Cawston TE, Hazleman BL and Mackie EJ (1996) Tenascin-C and human tendon degeneration. Am J Pathol 149: 933-943
23. Sakakura T (1995) role of tenascin in cancer development. In Tumor Matrix Biology. Adany R. (ed.), pp. 101-129. CRC Press: Boca Raton
24. Sakakura T, Ishihara A and Yatani R (1991) Tenascin in mammary gland development: from embryogenesis to carcinogenesis. In Regulatory Mechanisms in Breast Cancer, Lippman M and Dickson R. (eds), pp. 383-400, Kluwer Academic: Boston
25. Siri A, Carnemolla B, Saginati M, Leprini A, Casari G, Baralle F and Zardi L (1991) Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies. Nucleic Acids Res 19: 525-531
26. Sin A, Knauper V, Veirana N, Caocci F, Murphy G and Zardi L (1995) Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 270: 8650-8654
27. Soini Y, Paakko P, Nuorva K, Kamel D., Linnala A, Virtanen I and Lehto V-P (1993) Tenascin immunoreactivity in lung tumors. Am J Clin Pathol 100: 145-150
28. Stetler-Stevenson WG, Aznzvoorian S and Liotta LA (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573
29. Van Eyken P, Sciot R and Desmet VJ (1990) Expression of the novel extracellular matrix component tenascin in normal and diseased human liver: an immunohistochemical study. J Hepathol 11: 43-52
30. Vollmer G, Siegal GP, Chiquet-Ehrismann R, Lightre VA, Arnholdt H and Knuppen R (1990) Tenascin expression in the human endometrium and in endometrial adeinocarcinoma. Lab Invest 62: 725-730